Abvc Biopharma, Inc. SEC filings ECOC
Abvc Biopharma, Inc. has 795 filings in SEC EDGAR's recent list, going back to Jun 28, 2002. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, agreement ended, new debt, unregistered share sale, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Mar 3, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Mar 15, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Jun 6, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 16, 2021 | Dec 31, 2020 |
| 10-K | Annual report | May 15, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Apr 15, 2019 | Dec 31, 2018 |
| 10-KT | Transition report | Apr 13, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Jan 16, 2018 | Sep 30, 2017 |
| 10-K/A | Amended annual report | Sep 22, 2017 | Sep 30, 2016 |
| 10-K/A | Amended annual report | May 22, 2017 | Sep 30, 2016 |
| 10-K/A | Amended annual report | Feb 22, 2017 | Sep 30, 2016 |
| 10-K | Annual report | Jan 12, 2017 | Sep 30, 2016 |
| 10-K | Annual report | Nov 27, 2015 | Sep 30, 2015 |
| 10-K | Annual report | Apr 17, 2015 | Sep 30, 2014 |
| 10-K | Annual report | Apr 16, 2015 | Sep 30, 2013 |
| 10-K | Annual report | Apr 15, 2015 | Sep 30, 2012 |
| 10-K/A | Amended annual report | Dec 28, 2011 | Dec 15, 2011 |
| 10-K | Annual report | Dec 16, 2011 | Dec 15, 2011 |
| 10-K/A | Amended annual report | Jan 14, 2011 | Jan 14, 2011 |
| 10-K | Annual report | Jan 13, 2011 | Jan 12, 2011 |
| 10-K/A | Amended annual report | Jul 7, 2010 | Jul 7, 2010 |
| 10-K/A | Amended annual report | May 24, 2010 | May 21, 2010 |
| 10-K/A | Amended annual report | Feb 16, 2010 | Feb 16, 2010 |
| 10-K/A | Amended annual report | Feb 16, 2010 | Feb 16, 2010 |
| 10-K/A | Amended annual report | Feb 16, 2010 | Feb 16, 2010 |
| 10-K/A | Amended annual report | Feb 11, 2010 | Feb 10, 2010 |
| 10-K/A | Amended annual report | Feb 11, 2010 | Feb 10, 2010 |
| 10-K | Annual report | Dec 22, 2009 | Dec 22, 2009 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVC (Nasdaq), ECOC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1173313
- Former names
- American BriVision (Holding) Corp (until Apr 8, 2021); METU BRANDS, INC. (until Jan 8, 2016); Ecology Coatings, Inc. (until Sep 2, 2015); ECOLOGY COATINGS, INC. (until Sep 2, 2015); OCIS CORP (until Jun 13, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.